FDAnews Device Daily Bulletin

St. Jude Warning Letter Possible, CEO Says in 3Q Earnings Call

Oct. 25, 2012
A warning letter may be in St. Jude Medical’s future, company CEO Dan Starks announced during a Wednesday third quarter earnings call. The company experienced a rough quarter in general, with net sales of $1.3 billion, down 4 percent from the same period in 2011. Revenue overall grew less than 1 percent.
Devices & Diagnostics Letter